Table 2. Clinical characteristics of patients based on different Rab25 expression.
Characteristics | Total (n=154) | Low Rab25‡ (n=52) | High Rab25& (n=102) | P value |
---|---|---|---|---|
Age (year) | 63.5±11.7# | 64.9±10.6# | 0.429$ | |
Sex | 0.715$$ | |||
Male | 106 | 37 (34.9) | 69 (65.1) | |
Female | 48 | 15 (31.2) | 33 (68.8) | |
Tumor site | 0.439$$ | |||
Proventriculus | 37 | 15 (40.5) | 22 (59.5) | |
Corpora ventriculi | 41 | 11 (26.8) | 30 (73.2) | |
Sinuses ventriculi | 76 | 26 (34.2) | 50 (65.8) | |
Stage | 0.316$$$ | |||
I | 22 | 8 (36.4) | 14 (63.6) | |
II | 35 | 15 (42.9) | 20 (57.1) | |
III | 83 | 25 (30.1) | 58 (69.9) | |
IV | 14 | 4 (28.6) | 10 (71.4) | |
Differentiation | <0.001$$$ | |||
Well | 4 | 3 (75.0) | 1 (25.0) | |
Moderately | 52 | 29 (55.8) | 23 (44.2) | |
Poorly | 98 | 20 (20.4) | 78 (79.6) |
‡, IHC score: 0–5; &, IHC score: 6–12; #, mean ± SD); $, t-test; $$, chi-square test; $$$, Cochran-Armitage test for trend.